0
Skip to Content
PAREA
PAREA
Home
About
About
Members
Meet the Team
Learn
Why
FAQs
Governance
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
MEP Action Group
About
Members
Events
Latest
News
Events
Videos
Support Us
PAREA
PAREA
Home
About
About
Members
Meet the Team
Learn
Why
FAQs
Governance
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
MEP Action Group
About
Members
Events
Latest
News
Events
Videos
Support Us
Home
Folder: About
Back
About
Members
Meet the Team
Folder: Learn
Back
Why
FAQs
Folder: Governance
Back
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
Folder: MEP Action Group
Back
About
Members
Events
Folder: Latest
Back
News
Events
Videos
Support Us
  • Testimonies,
• 08/09/2022

Dave Pounds - MDMA for Alcohol Use Disorder

Dave Pounds was a participant in AWAKN Life Science's Clinical Trial - MDMA for Alcohol Use Disorder
Previous

Launch of the Psychedelic Access and Research European Alliance

Next

Webinar: Overcoming Roadblocks Making Psychedelic-Assisted Therapy a Reality

You Might Also Like

Related Embedded Video Item Thumbnail Psychedelic-assisted therapies in the treatment of brain disorders - European Parliament
Related Embedded Video Item Thumbnail DAVOS: Brain Capital, Psychedelics & Human Flourishing
Related Embedded Video Item Thumbnail SA TAIP seminar | "Models for psychedelic assisted therapies: the needs and the solutions"
Related Embedded Video Item Thumbnail Maryam Jabir - challenging, unresolved psychedelic experience: psilocybin therapy for treatment resistant depression
Related Embedded Video Item Thumbnail Launch of the Psychedelic Access and Research European Alliance

Contact

tadeusz@parea.eu

Our Work

About
Why

© Parea 2024 | Privacy Policy